| Dr Carl J Lockwood, DMD | |
|
9020 Farrow Road, Columbia, CA 29203 | |
| (803) 419-5002 | |
| (803) 419-9600 |
| Full Name | Dr Carl J Lockwood |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 9020 Farrow Road, Columbia, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225059645 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | SC2116 (South Carolina) | Primary |
| 1223G0001X | Dentist - General Practice | SC (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carl J Lockwood, DMD 320 Longtown Rd W, Blythewood, SC 29016-8165 Ph: (803) 333-9904 | Dr Carl J Lockwood, DMD 9020 Farrow Road, Columbia, CA 29203 Ph: (803) 419-5002 |
News Archive
A non-invasive, patient-friendly imaging technique can help physicians make treatment decisions for breast cancer patients when diagnostic dilemmas arise.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the execution of multiple commercial supply agreements with its existing manufacturing partners. Halozyme amended an existing commercial supply agreement with Avid Bioservices, Inc., entered into a new commercial supply agreement with Avid and entered into a new commercial supply agreement with Cook Pharmica LLC.
A new study, conducted by researchers from the Institut Pasteur in Paris and the Centre for Genomic Regulation (CRG) in Barcelona, have revealed that Leishmania adaptation is a consequence of reversible and frequent chromosomal amplifications.
The researchers reviewed 72 randomized trials and 9,991 patients who had chronic hepatitis C for more than six months and were previously untreated, who had relapsed after treatment or who had not responded to other treatment.
A new study, conducted by researchers from the Institut Pasteur in Paris and the Centre for Genomic Regulation (CRG) in Barcelona, have revealed that Leishmania adaptation is a consequence of reversible and frequent chromosomal amplifications.
› Verified 9 days ago